Key result
Simultaneous implantation of a Watchman left atrial appendage occluder and a Micra leadless pacemaker through a single right femoral vein access was successful with no complications at 1 month.
Why the study?
Is it feasible and safe to implant a left atrial appendage occluder and a leadless pacemaker through the same venous access in a single sitting in a patient with AF and tachy-brady syndrome?
Case Report (n=1)
No
Is it feasible and safe to implant a left atrial appendage occluder and a leadless pacemaker through the same venous access in a single sitting in a patient with AF and tachy-brady syndrome?
Demonstrates the feasibility and safety of implanting both a left atrial appendage occluder and a leadless pacemaker through a single venous access in one sitting.
Single-access combined Watchman-Micra implantation succeeded without short-term issues; hypothesis-generating and leaves open need for larger prospective studies.
A left atrial appendage occluder device (Watchman) and leadless pacemaker (Micra) was implanted from a single right femoral vein access in a 73-year-old female patient with persistent atrial fibrillation and symptomatic tachy-brady syndrome and unable to take oral anticoagulants. Standard methods of implantation were followed for both procedures. The Watchman device was implanted first followed by dilatation of the same venous access site in order to implant Micra transcatheter pacing system. The patient tolerated the procedures well and there were no complications. At the end of 1 month, both the devices were found to be working well.
No takes yet. Share an insight, caveat, or question.
Johar et al. (2018) conducted a case report in Persistent atrial fibrillation and symptomatic tachy-brady syndrome (n=1). Simultaneous Watchman and Micra implantation via single venous access was evaluated on Procedural success and device function at 1 month. Simultaneous implantation of a Watchman left atrial appendage occluder and a Micra leadless pacemaker through a single right femoral vein access was successful with no complications at 1 month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: